What is the formulation of the EpiPen (epinephrine) auto‑injector?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

EpiPen Formulation

The EpiPen auto-injector contains epinephrine (adrenaline) in a 1:1000 concentration (1 mg/mL) as a sterile aqueous solution, with EpiPen delivering 0.3 mg in 0.3 mL and EpiPen Jr delivering 0.15 mg in 0.3 mL. 1

Active and Inactive Ingredients

Each 0.3 mL solution in both EpiPen formulations contains:

Active ingredient:

  • EpiPen: 0.3 mg epinephrine
  • EpiPen Jr: 0.15 mg epinephrine

Inactive ingredients (identical in both formulations):

  • 1.8 mg sodium chloride
  • 0.5 mg sodium metabisulfite (as preservative/antioxidant)
  • Hydrochloric acid (for pH adjustment)
  • Water for Injection
  • pH range: 2.2–5.0 1

Chemical Structure and Stability

Epinephrine is chemically designated as (-)-3,4-Dihydroxy-α-[(methylamino)methyl]benzyl alcohol, a sympathomimetic catecholamine. 1 The solution deteriorates rapidly when exposed to air or light, turning pink from oxidation to adrenochrome and brown from melanin formation. Discard the device if the solution appears discolored (pinkish or brown), cloudy, or contains particles. 1

Clinical Dosing Context

The fixed-dose formulations reflect standard anaphylaxis dosing of 0.01 mg/kg intramuscularly, with the 0.15 mg dose designed for children weighing approximately 15 kg (33 lbs) and the 0.3 mg dose for those weighing approximately 30 kg (66 lbs) or more. 2 Both doses are dispensed across nearly the entire pediatric age range in practice, though this creates potential for over- or underdosing in infants and adolescents. 2, 3

Important caveat: The sodium metabisulfite preservative may cause allergic-type reactions including anaphylaxis in susceptible individuals, particularly those with asthma. However, there is no absolute contraindication to epinephrine use in anaphylaxis, as the benefit outweighs this theoretical risk. 1

References

Research

Epinephrine dispensing for the out-of-hospital treatment of anaphylaxis in infants and children: a population-based study.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.